Details for 2017729263

Up to date per 01.04.2026

Actions

Title / Product Name

(2S)-1-[4-(3,4-DICHLORPHENYL)PIPERIDIN-L-YL]-3-[2-(5-METHYL-L,3,4-OXADIAZOL-2-YL)BENZO[B]FURAN-4-YLOXY]PROPAN-2-OL ODER METABOLIT DAVON ZUR BEHANDLUNG VON ANGSTZUSTÄNDEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017729263

EP Publication Number

3463357

E-Number

1612886

Language

PCT Number

US17034036

Publication Date

10.04.2019 A

20.09.2023 B1

Registration Date

20.09.2023

AT Publication Date

15.10.2023

Application Date

23.05.2017

Registration Number

Priorities

25.05.2016

201662341517 P

11.08.2016

201662373720 P

IPC

A61K 31/454 20060101AFI20171201BHEP

Maximum Duration of Protection

23.05.2037

Owner

Minerva Neurosciences, Inc.1500 District Avenue Burlington, MA 01803US

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT

Inventor

LUTHRINGER, Remy1 Bis Rue du Tir 1204 GenevaCH

Information about Fees